Oracle (ORCL) Stock Forecast & Price Target

Q: What analysts cover Oracle?

Oracle has been rated by research analysts at Argus , Barclays , BMO Capital Markets , Cantor Fitzgerald , Citigroup , Citizens Jmp , CLSA , DA Davidson , DZ Bank , Freedom Broker , Guggenheim , Jefferies Financial Group , JPMorgan Chase & Co. , KeyCorp , Morgan Stanley , Oppenheimer , President Capital , Rothschild & Co Redburn , Royal Bank Of Canada , Sanford C. Bernstein , Scotiabank , Stephens , Stifel Nicolaus , TD Cowen , The Goldman Sachs Group , UBS Group , and Weiss Ratings in the past 90 days.

$137.48 -3.92 (-2.77%)

Closing price 03:59 PM Eastern

Extended Trading

$136.90 -0.58 (-0.42%)

As of 07:59 PM Eastern

Compare

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 47 Analyst Ratings

Sell
1

Hold
9

Buy
37

Based on 47 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 47 analysts, 1 has given a sell rating, 9 have given a hold rating, 36 have given a buy rating, and 1 has given a strong buy rating for ORCL.

Consensus Price Target

$251.72
83.10% Upside

According to the 47 analysts' twelve-month price targets for Oracle, the average price target is $251.72. The highest price target for ORCL is $400.00, while the lowest price target for ORCL is $110.00. The average price target represents a forecasted upside of 83.10% from the current price of $137.48.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ORCL Analyst Ratings Over Time

Type	Current Forecast 10/12/25 to 10/12/26	1 Month Ago 9/12/25 to 9/12/26	3 Months Ago 7/14/25 to 7/14/26	1 Year Ago 10/12/24 to 10/12/25
Strong Buy	1 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	3 Strong Buy rating(s)
Buy	36 Buy rating(s)	32 Buy rating(s)	32 Buy rating(s)	25 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	7 Hold rating(s)	9 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$251.72	$254.76	$264.63	$308.64
Forecasted Upside	83.10% Upside	69.69% Upside	106.81% Upside	5.32% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oracle Stock vs. The Competition

Type	Oracle	Technology Companies	Broader Market
Consensus Rating Score	2.79	2.23	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	83.10% Upside	646.14% Upside	19.27% Upside
News Sentiment Rating	Positive News See Recent ORCL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/2/2026	Citigroup 4 of 5 stars	Tyler Radke 1 of 5 stars	Reiterated Rating	Market Outperform
10/2/2026	Citizens Jmp 4 of 5 stars	Patrick Walravens 1 of 5 stars	Reiterated Rating	Market Outperform	$285.00	+106.39%
9/25/2026	Sanford C. Bernstein 3 of 5 stars	Mark L. Moerdler Not Rated	Reiterated Rating	Buy
9/17/2026	DZ Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
9/14/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$239.00 ➝ $240.00	+80.94%
9/14/2026	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Egor Tolmachev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$210.00 ➝ $205.00	+41.88%
9/14/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Bonner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$225.00	+49.87%
9/11/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$245.00 ➝ $250.00	+59.94%
9/11/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$220.00 ➝ $200.00	+30.57%
9/11/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$250.00 ➝ $252.00	+64.52%
Get the Latest News and Ratings for ORCL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oracle and its competitors with MarketBeat's FREE daily newsletter.
9/11/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$285.00	+86.07%
9/11/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Perform	$190.00 ➝ $165.00	+5.53%
9/11/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$225.00	+43.90%
9/11/2026	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Equal Weight	$175.00	+14.25%
9/11/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$220.00 ➝ $195.00	+27.31%
9/11/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$229.00 ➝ $284.00	+85.41%
9/10/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$320.00 ➝ $290.00	+118.64%
9/10/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
9/9/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$300.00 ➝ $240.00	+48.39%
9/9/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Outperform	$241.00 ➝ $215.00	+33.19%
9/8/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$375.00 ➝ $400.00	+152.13%
9/8/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$235.00 ➝ $275.00	+73.34%
9/4/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$207.00 ➝ $210.00	+35.92%
7/20/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold (C+) ➝ Hold (C)
7/20/2026	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bhavtosh Vajpayee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Hold	$145.00	+14.64%
7/20/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Sell	$155.00 ➝ $110.00	-17.07%
7/14/2026	President Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Overweight	$360.00 ➝ $300.00	+126.18%
6/15/2026	Phillip Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$275.00 ➝ $237.00	+78.68%
6/12/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$345.00 ➝ $316.00	+138.24%
6/12/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$283.00 ➝ $290.00	+118.64%
6/11/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$275.00 ➝ $240.00	+33.18%
6/11/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$275.00 ➝ $225.00	+11.92%
6/11/2026	Moffett Nathanson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$325.00	+61.66%
6/11/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$210.00 ➝ $225.00	+11.92%
6/10/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$375.00 ➝ $300.00	+126.18%
6/9/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$200.00 ➝ $240.00	+13.39%
6/8/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$220.00 ➝ $245.00	+14.80%
6/5/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Difucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$400.00	+69.12%
6/3/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Outperform	$400.00 ➝ $320.00	+30.72%
5/7/2026	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target	Neutral ➝ Buy	$255.00	+31.31%
Your book is inside (Ad) The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today. Download your copy now.
3/13/2026	Citic Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Buy	$243.00 ➝ $200.00	+50.78%
3/11/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Neutral ➝ Hold
3/10/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$300.00 ➝ $200.00	+31.98%
2/9/2026	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Reitzes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$160.00	+2.82%
12/3/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Equal Weight ➝ Overweight	$280.00	+39.15%
11/10/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold
10/20/2025	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Neutral
10/17/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
6/18/2025	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold
6/18/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Strong-Buy
6/12/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$195.00 ➝ $246.00	+39.51%
6/10/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$135.00	-23.99%
6/9/2025	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:54 PM ET.

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 8, 2026. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

Here are some ways that investors could benefit from investing in Oracle:

Oracle recently reported strong financial performance for the quarter ended September 10, 2026, beating consensus estimates with earnings per share of $1.92 compared to the expected $1.74 and revenue of $19.34 billion, which exceeded the $19.13 billion forecast, demonstrating robust demand for its cloud infrastructure and AI services.
The stock is currently trading at $135.35, which is significantly below the consensus price target of $251.72 set by analysts who maintain a Moderate Buy rating, suggesting substantial potential for upside recovery as the market digests recent volatility.
Oracle is aggressively securing renewable energy resources to support its data center expansion, including a virtual power purchase agreement for Scout Clean Energy’s 300-megawatt Ranchero Wind Farm in Texas, which helps mitigate power constraints and supports its planned investment in over 1.7 gigawatts of renewable projects.
Analysts such as Mizuho have added Oracle to their Top Picks list with a $320 price target, citing accelerating demand for Oracle Cloud Infrastructure and AI-related cloud services, indicating strong institutional confidence in the company's growth trajectory despite recent market headwinds.
Oracle maintains a consistent dividend yield of 1.38%, with a recent quarterly dividend of $0.50 per share, providing a steady income stream for investors while the company continues to generate high returns on equity of 48.85%.

Oracle
Bear Case

Investors should be bearish about investing in Oracle for these reasons:

Oracle is facing significant leverage concerns as it pursues debt deals worth tens of billions of dollars to fund AI hardware, with reports indicating it is exploring financing structures where private-credit investors purchase AI chips and lease them to the company, raising risks related to financing costs and potential obsolescence of expensive chips before debt matures.
Operational delays at the Project Jupiter AI campus in New Mexico have forced Oracle to consider using trucks to deliver natural gas to maintain construction schedules, highlighting logistical challenges and increased costs that could delay data-center capacity coming online.
There are concerns that Oracle locked in fixed-margin cloud deals just before GPU prices soared, meaning the company cannot benefit from the recent sharp increases in GPU rental prices seen by competitors like CoreWeave and Nebius, potentially squeezing margins in the AI infrastructure sector.
The stock has experienced a sharp decline, falling 5.7% to $135.35 on October 8, 2026, driven by broader AI sector sell-offs triggered by reports that OpenAI’s annualized revenue is roughly $20 billion below previous estimates, which has heightened investor anxiety about the sustainability of AI-driven growth.
Oracle's debt-to-equity ratio stands at 1.89, reflecting a high level of financial leverage that may limit its flexibility in a volatile market environment where interest rates and financing costs for large-scale AI infrastructure projects remain a key concern for investors.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 47 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $251.72, with a high forecast of $400.00 and a low forecast of $110.00.

47 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last twelve months. There is currently 1 sell rating, 9 hold ratings, 36 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted upside of 83.10% based on their 12-month stock forecasts.

Over the previous 90 days, Oracle's stock had 1 downgrade by analysts.

Oracle has been rated by research analysts at Argus, Barclays, BMO Capital Markets, Cantor Fitzgerald, Citigroup, Citizens Jmp, CLSA, DA Davidson, DZ Bank, Freedom Broker, Guggenheim, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Oppenheimer, President Capital, Rothschild & Co Redburn, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Stephens, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, UBS Group, and Weiss Ratings in the past 90 days.

Analysts like Oracle more than other "technology" companies. The consensus rating for Oracle is Moderate Buy while the average consensus rating for "technology" companies is Hold. Learn more on how ORCL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

MarketBeat monitors more than a dozen sources for Oracle analyst ratings, with the most recent rating issued on 10/2/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oracle (ORCL) Stock Forecast & Price Target